Who Paid My Doc
PhIII Ide-Cel vs Triplet Regimens RRMM 3L (bb2121-MM-003; KarMMa-3) - A Phase 3, Multicenter, Randomized, Open-label Study to Compare the Efficacy and Safety of bb2121 Versus Standard Regimens in Subjects with Relapsed and Refractory Multiple Myeloma (RRM
Research payments
$7,637,725
Through program year 2024, $7,637,725 in research payments was reported against PhIII Ide-Cel vs Triplet Regimens RRMM 3L (bb2121-MM-003; KarMMa-3) - A Phase 3, Multicenter, Randomized, Open-label Study to Compare the Efficacy and Safety of bb2121 Versus Standard Regimens in Subjects with Relapsed and Refractory Multiple Myeloma (RRM, across 74 payments, paid by Celgene Corporation.
- Paid by
- Celgene Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $2,021,299 | 38 |
| 2023 | Research | $5,513,058 | 32 |
| 2022 | Research | $103,368 | 4 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Noopur Raje Boston, MA Named on 5 payments
- Rachid Baz Tampa, FL Named on 4 payments
- Scott Solomon Atlanta, GA Named on 3 payments
- Luciano Costa Birmingham, AL Named on 3 payments
- Sundar Jagannath Paramus, NJ Named on 3 payments
- Al-Ola Abdallah Westwood, KS Named on 2 payments
- Yi Lin Rochester, MN Named on 2 payments
- Houston Holmes Dallas, TX Named on 2 payments
- Seema Singhal Chicago, IL Named on 2 payments
- Sikander Ailawadhi Jacksonville, FL Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.